Rafael Holdings Inc

Company Profile

• Business description

  Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

• Contact

  520 Broad Street
  NewarkNJ07102
  USA

  T: +1 212 658-1450

  E: [email protected]

  https://www.rafaelholdings.com

• Sector

  Real Estate

  Stock type

  Cyclical

• Industry

  Real Estate Services

  Fiscal Year End

  31 July 2026

  Employees

  23